Issue 46, 2024

Low temperature synthesis of franklinite stabilized cefixime as a multifunctional nanoformulation

Abstract

Cefixime, an antibiotic with low solubility, stability, bioavailability and therapeutic effectiveness, needs to be administered in larger doses for effective treatment. This can lead to higher healthcare costs and increased risk of side effects, negatively affecting public health. Herein, we aim to develop a strategy to overcome the aforementioned limitations by stabilizing it using franklinite nanostructures. Franklinite nanostructures (ZnFe2O4) were synthesized via a green method and subsequently used as a support to stabilize cefixime (Cef). The successful formation of ZnFe2O4 nanostructures and subsequent loading of the drug was confirmed using various microscopic and spectroscopic analyses. Solubility measurements and dissolution tests for the franklinite stabilized cefixime (Cef–ZnFe2O4) indicated increased solubility, enhanced in vitro bioavailability and greater absorption under physiological conditions. Hemolytic assay affirmed the safety and efficacy of drug stabilized by franklinite. Biological assessment of Cef–ZnFe2O4 revealed that it has strong antifungal, antioxidant and kinase inhibition potential as compared to its bare counterpart. These findings emphasize the potential of newly designed Cef–ZnFe2O4 as a promising nanoformulation with enhanced solubility, efficacy, safety and biological activities.

Graphical abstract: Low temperature synthesis of franklinite stabilized cefixime as a multifunctional nanoformulation

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
06 Sep 2024
Accepted
12 Oct 2024
First published
06 Nov 2024
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2024,14, 34156-34164

Low temperature synthesis of franklinite stabilized cefixime as a multifunctional nanoformulation

A. Munsaf, M. N. Ahmed, A. Zafar, B. Akram and M. A. A. Ibrahim, RSC Adv., 2024, 14, 34156 DOI: 10.1039/D4RA06435F

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements